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tor salivary glands increased to 18 month and
next diminished to 60 months. For spinaJ cord
there was observed signiticant progression ot
intensity late toxicity (mild tunctional) during
second year after irradiation.
Conclusions:
1. SOMA-LENT scale seems to be adequate in
the clinical practice tor the estimation ot late
radiation toxicity ot H&N region tissues.
2. Ongoing study has preliminary nature and is
being continued.
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OF A METHOD AND A REVIEW OF
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Introduction: Pulsed Dose Rate (POR)
treatment is a new brachytherapy modality that
combines·physical adventages ot high-dose-rate
(HDR) technology (isodose optimization,
radiation satety) with the radiobiological
adventages ot low-dose-rate (LOR)
brachytherapy.
Pulsed brachytherapy consists ot using a
stronger radiation source than tor LOR
brachytherapy and is giving a senes ot short
exposures ot 10 to 30 minutes in every hour to
approximately the same tataI dose in the same
overall as with the LOR. Modern afterloading
equipment offers some advantages over
intersitial or intracavitary insertion ot separate
needles, tubes, seeds or wires. Isodose
volumes in tissue can be created tlexibly by a
combination ot caretuJ placement ot the catheter
and adjustment ot the dwell times ot the
computerized stepping source. Automatic
removal ot the radiation sources into a shielded
sate eliminates radiation exposures to statt and
visitors. Radiation exposure is also eliminated to
the staff who tormerly loaded and unloaded a
multiplicity ot radioactive sources into the
catheters, ovoids, tubes etc.
Material and methods: This retrospective
study based on summarized clinical
investigations analyses the teasibility,
differences between methods ot brachytherapy
and preliminary oncologic results ot POR
brachytherapy.
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Since July 2000 15 patients were treated in
Greatpoland Cancer Center using POR
brachytherapy. They were 10 patients with
recurrent brain malignant glioma, 2 with
recurrent nasopharyngeal cancer, and patients
with lip cancer, recurrent breast cancer and
recurrent salivary gland cancer. Only patient
with lip cancer was treated radically. Nucietron
POR unit with 1 Ci source and PLATO planning
system were used.
Results: Short time ot observation doesn't
allow to draw a radical conclusions. On the
ground ot Iiterature and preliminary own results
it seems that POR brachytherapy is save and
efficient method ot treatmenł. The most
important compJication was a local infection in
place of implanted catheter. In some cases (tor
example in patients with recurrent malignant
glioma after teletherapy) POR brachytherapy
perhaps could be a treatment ot choice.
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Background: Repopulation during radiation
therapy may compromise the results ot the
treatment ot NSCLC. In spite ot the data
showing an improvement ot therapeutic ratio
with shortening ot the total treatment time, there
is no univoque way ot doing ił. Current study
was conducted to compare two different
regimens ot accelerated radiotherapy.
Material/Methods: From March 1999 to
November 2000 torty patients with stage III
NSCLC were included. Twenty-eight pts. (70%)
received 3-4 cycles ot induction chemotherapy
(cis-platinum, vepeside). Twenty-six p. were
treated according to RAHIP schema, 14 pts.
according to RT-BOOST schedule. RAHIP
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consisted in radiotherapy twice-daily delivered:
first week: 2x1,20 Gy "elective fields", the
remaining three weeks 1,80 Gy "elective fields"
and 1,20 Gy boost on involved areas by oblique
fields. Total dose was 57 Gy. Conventional
treatment techniques were employed. RT-
BOOST technique was conformally planned and
delivered, total dose was 56,7 Gy in 21 fractions
(per fraction: 1,9 Gy to limited elective areas and
concurrent boost of 0,8 Gy to the GTV) and 26
days.
Results: With a follow-up period ranging from
1 to 19 months, there is no difference in the
compliance with the treatment-plan, treatment
tolerance and response rate in the two analysed
groups. In all but two patients treatment plan
was realised. In RT-BOOST group treatment
was discontinued in one patient, because of
prolonged IW EORTC/RTOG oesophageal
toxicity. In RAHIP group in one patient treatment
was prolonged by 10 days because of
pneumonitis (W lung toxicity). One case of IW
oesophageal toxicity was observed in each
group. There was no increase in toxicity among
patients receiving chemotherapy before
radiotherapy. The response rate was similar in
both analysed groups (RAHIP: 73% PR, 7,5%,
CR; RT-SOOST: 65% PR, 7% CR). Estimated
by Kaplan-Meier actuarial one-year survival rate
method was 66% and actuarial one-year
progression free-survival rate was 58% for the
entire group.
Conclusions: Preliminary results of
accelerated radiotherapy for locally advanced
NSCLC seem promising. Additionally a good
compliance with the treatment in both groups
allows to work out a phase III study dealing with
this problem.
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Aim: The evaluation what kind of statistical
informations concomitant with DVH are essential
in estimations of dose distribution in conformal
planning of radiotherapy.
Method: Un the base of test case -- cancer of
the base of tongue, irradiation plans for different
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sizes of irradiation boost field margins were
analysed. DVHs - differential and cumulative for
selected critical organs and target volume have
been accounted. On base of standard deviation
and minimai doses in select volumes target and
critical tissues have been estimated. Then
probability of local control the risk of
complications have been expected.
Results and discussion: The modelled
results show, that graphic representation of DVH
is not sufficient information itself in estimation of
dose distribution. Statistical parameters like
modal dole, standard deviation determine
essential supplement of graphic dose
distribution. Especially standard deviation
contains indispensable information. The
histogram differential and cumulative should be
used together for estimations of dose
distribution. It appears that estimation of dose
distribution in target volume should be based on
cumulative histogram and estimation of dose
distribution in critical organs - on differential
histogram.
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Purpose: Presentation of quality control
system being in force in Kielce and results of
patients' setup reproducibility and repeatability.
System description: Almost all patients
treated in our hospital begin theirs treatments on
Monday. For every patient treated with radical
intent portal films are taken and compared with
reference images obtained at simulator during
the first fraction. After digitizing of both portal
and reference films the comparison is performed
by means of PIPS·PRO software. Comparison
has to be completed until Wednesday morning
when results are presented to radiotherapists on
check meeting. Action levels specific to
individuallocalization are defined and if
difference between portal and reference film
exceeds the specific level, another portal film is
taken on the next day. If the difference still
exceeds the action level the patient is directed
again to simulator and the procedure starts from
the very beginning. Until 31.01.2001 more than
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